In human breast cancer, it was already postulated that vaccination could induce an expansion of CD8+ cytotoxic T-lymphocytes capable of rejecting tumor cells via recognition of tumor-associated antigenic epitopes, located on the surface of cancer cells [99, 100]. The gene discussed is CD8A; the disease is neoplasm.